The global infection control market is expected to grow from USD 50.411 billion in 2025 to USD 62.063 billion in 2030, at a CAGR of 4.25%.
Infection control is the practice and procedures which can be used to minimize the risk of spreading infections and viruses especially in hospitals and human or animal care facilities. The diseases caused by bacteria or viruses can spread easily from human to human, animal to animal, human contact with infected surfaces, might be airborne and the practices involved in preventing this is known as Infection control.
The primary driver of the market is the growing hospital-acquired Infections, which can occur during the patient's stay at the hospital facility which is also one of the primary mortality causes. One of the primary reasons for these diseases is the use of the same medical equipment during the diagnosing procedure which can cause diseases such as ventilator-associated pneumonia, catheter-associated urinary tract infections, central line-associated bloodstream infections, surgical-site infections.
The contacting of these diseases mainly depends upon the patient’s immune system, their infection control practices, the presence of various infectious agents in the hospital facility. Age and longer stays at the facilities are also primary reasons for the cause of these diseases. The most common bacteria associated with HAIs include C. difficile, MRSA, Klebsiella, E. coli, Enterococcus, and the Pseudomonas species, and also with the outbreak of COVID-19 the healthcare facilities have led to practicing infection control as the virus is the person to person transmissible.
Due to all these reasons, the infection control market has seen a large growth owing to the proper use of sterilization and disinfecting practices being used in healthcare facilities.
By end-user industry, the global infection control market is expected to grow at a high CAGR owing to the high Hospital Acquired Infections (HAI), the increasing number of surgical procedures; the growing geriatric population, and increasing incidence of chronic diseases; the growing focus on food sterilization and disinfection; technological advancements in sterilization equipment; and the increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers. Also owing to the COVID-19 scenario the market is expected to grow at high due to the demand for self and surface disinfectants like masks, sanitizers, etc. Also, the technological advancements in many countries and the growing pharmaceutical industry in many countries, increasing use of E-beam sterilization, re-introduction of ethylene oxide sterilization has led to an immense amount of growth in the market. North America is expected to account for the largest share of the infection control market during this period.
Hospital Acquired Infections are the infections that are acquired in hospitals and other health care facilities. HAIs are caused by viral, bacterial, and fungal pathogens. The most common infections are bloodstream infections (BSIs), pneumonia, urinary tract infections (UTIs), and surgical site infections (SSIs). These are caused due to the lack of hospitality equipment sterilization which is cleansing and passed from the patient-to-patient transmission. The most common types of HAIs cost around $9.8 billion annually in the U.S., with SSIs contributing the largest share of 33.7% ($3.3 billion). The reasons behind the high cost of SSIs are prolonged hospitalization of patients and associated diagnostic tests & treatment. Hence to reduce this proper care must be taken which will control the rate of infection.
As we all know all surface disinfectants, sanitizers, sterilizers have chemicals inbound in them that may be harmful after continuous exposure to humans as they may have toxic properties. For example, sodium hypochlorite is an effective treatment against blood-borne pathogens but is also highly corrosive and a respiratory irritant, which makes it dangerous for cleaning personnel and building occupants and toxic when released into the environment. The improper use of these disinfectants can cause environmental hazards and be harmful to patients exposed to them. There is no green certificate currently available for disinfectants and sterilizers being used in the market. Due to the increasing population demanding a greener solution, the use of disinfectants is becoming limited, with their use being controlled. Manufacturers are now being forced to develop newer, greener alternatives that are less corrosive to the human eyes, such as butyl-free, pH-neutral quaternary, and hydrogen peroxide-based disinfectants.
The market leaders for the infection control market consist of 3m, Belimed, Cantel Medical, MMM Group, Sterigenics International LLC, STERIS plc, HYH, Matachana Group, Olympus Corporation, Medtronic are some of the key players in the market. These companies manufacture healthcare units, sterilization equipment’s and other disinfecting and cleaning products.
Global Infection Control Market Segments: